Impact of the COVID‐19 pandemic on provision of interventional cardiology and cardiac surgery services in Australia: a review of Medicare claims data
Internal Medicine Journal · 2024
DOI: 10.1111/imj.16342 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Internal Medicine Journal, 2024. Verfasst von Hari P Sritharan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Royal North Shore Hospital, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: COVID-19, Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
The coronavirus disease 2019 (COVID‐19) pandemic has significantly impacted healthcare service provision worldwide. There is limited information on changes in invasive cardiovascular services during the pandemic, particularly in Australia.
Aim
We sought to assess temporal trends on the use of interventional cardiology and cardiac surgery services before and following the COVID‐19 pandemic in Australia.
Methods
Medicare Benefits Schedule items data from the Australian Government Services Australia on outpatient and private hospital interventional cardiology procedures (coronary angiogram, percutaneous coronary intervention and transcatheter aortic valve implantation) and cardiac surgery procedures (coronary artery bypass grafting [CABG] and surgical valve replacement, repair and annuloplasty) were analysed from March 2019 to 2021. This was superimposed on monthly COVID‐19 case data obtained from the Australian Department of Health and Aged Care epidemiology reports.
Results
A sustained reduction in CABG (−10.1%) and surgical valve intervention (−11.1%) was appreciated from March 2019–2020 to March 2020–2021, in the first year of the COVID‐19 pandemic. During this period, an overall increase (+25.9%) in the use of transcatheter aortic valve implantation was observed. Following the initial period of mandated isolation in March–April 2020, a reduction in coronary angiography (−29.1%) and percutaneous coronary intervention (−19.5%) was observed in comparison to March–April 2019; however, this was largely attenuated over time.
Conclusions
The COVID‐19 pandemic has resulted in reductions in the use of interventional cardiology and cardiac surgery services, with cardiac surgery most affected. However, an increase in uptake of transcatheter aortic valve implantation has been observed during the pandemic. This may have implications for future planning and resource allocation in the aftermath of the pandemic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Royal North Shore Hospital, Sydney, New South Wales, Australia.
- Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
- Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia.
ORCID-Profile: Hari P Sritharan
Zitieren
APA
Sritharan, H. P., Bhat, A., Chia, J., Allahwala, U. K., & Bhindi, R. (2024). Impact of the COVID‐19 pandemic on provision of interventional cardiology and cardiac surgery services in Australia: a review of Medicare claims data. Internal Medicine Journal. https://doi.org/10.1111/imj.16342
Vancouver
Sritharan HP, Bhat A, Chia J, Allahwala UK, Bhindi R. Impact of the COVID‐19 pandemic on provision of interventional cardiology and cardiac surgery services in Australia: a review of Medicare claims data. Internal Medicine Journal. 2024. doi:10.1111/imj.16342
BibTeX
@article{Sritharan2024,
author = {Sritharan, Hari P and Bhat, Aditya and Chia, Justin and Allahwala, Usaid K and Bhindi, Ravinay},
title = {Impact of the COVID‐19 pandemic on provision of interventional cardiology and cardiac surgery services in Australia: a review of Medicare claims data},
journal = {Internal Medicine Journal},
year = {2024},
doi = {10.1111/imj.16342}
}
EUVIMED